Skip to Content

Bryan M. Fellman, M.S.

Research Statistical Analyst


  • M.S. in Statistics, Texas A&M University, College Station, TX
  • B.S. in Applied Mathematics, Texas A&M University, College Station, TX


Bradford A, Fellman B, Urbauer D, Gallegos J, Meaders K, et al. Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers. Gynecol Oncol. 2015 Aug 29.

Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, et al. Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int. 2015 Jun 5.

Dempsey KM, Broaddus R, You YN, Noblin SJ, Mork M, et al. Is it all Lynch syndrome?: An assessment of family history in individuals with mismatch repair-deficient tumors. Genet Med. 2015;17(6):476-484.

Karam JA, Devine CE, Fellman BM, Urbauer DL, Abel EJ, et al. Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial. BJU Int. 2015 Jun 1.

Okoye EI, Bruegl AS, Fellman B, Luthra R, Broaddus RR. Defective DNA mismatch repair influences expression of endometrial carcinoma biomarkers. Int J Gynecol Pathol. 2015 Apr 2.

Fellman B, Yuan Y. Bayesian optimal interval design for phase I oncology clinical trials. The Stata Journal. 2015; 15(1):110-120.

Yusuf RA, Rogith D, Hovick SR, Peterson SK, Burton-Chase AM, et al. Attitudes toward molecular testing for personalized cancer therapy. Cancer. 2015; 121(2):243-50. 

Fellman B, Ensor J. A command for significance and power to test for the existence of a unique most probable category. The Stata Journal. 2014; 14(3):499-510.

Brassil KJ, Szewczyk N, Fellman B, Neumann J, Burgess J, et al. Impact of an incentive-based mobility program, "Motivated and Moving," on physiologic and quality of life outcomes in a stem cell transplant population. Cancer Nurs. 2014; 37(5):345-354. 

Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, et al. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014; 134(3):546-551.

Batte BA, Bruegl AS, Daniels MS, Ring KL, Dempsey KM, et al. Consequences of universal MSI/IHC in screening ENDOMETRIAL cancer patients for Lynch syndrome. Gynecol Oncol. 2014;134(2):319-325.

Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, et al. Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. Cancer Prev Res (Phila). 2014; 7(7):686-697.

Fellman B. Stata command for calculating adverse event and efficacy stopping boundaries for phase II single arm trials. The Stata Journal. 2014; 14(2):407-417.

Huang J, Hu W, Bottsford-Miller J, Liu T, Han HD, et al. Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to dasatinib. Clin Cancer Res. 2014; 20(7):1846-55. 

Huang M, Iglesias DA, Westin SN, Fellman B, Urbauer D, et al. Pelvic exenteration: impact of age on surgical and oncologic outcomes. Gynecol Oncol. 2014; 132(1):114-118.

LoBiondo-Wood G, Brown CG, Knobf MT, Lyon D, Mallory G, et al. Priorities for oncology nursing research: the 2013 national survey. Oncol Nurs Forum. 2014; 41(1):67-76. 

Schover LR, Yuan Y, Fellman BM, Odensky E, Lewis PE, et al. Efficacy trial of an Internet-based intervention for cancer-related female sexual dysfunction. J Natl Compr Canc Netw. 2013; 11(11):1389-1397. 

Parker PA, Urbauer D, Fisch MJ, Fellman B, Hough H, et al. A multisite, community oncology-based randomized trial of a brief educational intervention to increase communication regarding complementary and alternative medicine. Cancer. 2013; 119(19):3514-3522.

Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, et al. Randomized controlled trial of a sun protection intervention for children of melanoma survivors. Cancer Epidemiol Biomarkers Prev. 2013; 22(10):1813-1824.

Parker PA, Alba F, Fellman B, Urbauer DL, Li Y, et al. Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. Eur Urol. 2013; 63(6):1122-1127. 

Urh A, Soliman PT, Schmeler KM, Westin S, Frumovitz M, et al. Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies. Gynecol Oncol. 2013; 129(3):580-585. 

Berger JL, Westin SN, Fellman B, Rallapali V, Frumovitz M, Ramirez PT, Sood AK, Soliman PT. Modified vertical rectus abdominis myocutaneous ap vaginal reconstruction: an analysis of surgical outcomes. Gynecologic Oncology 2012; 125(1): 252-255.

Hui D, Kilgore K, Fellman B, Urbauer D, Hall S, Fajardo J, Rhondali W, Kang JH, Del Fabbro E, Zhukovsky D, Bruera E. Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients (IMPACT) score: a preliminary study. Journal of Palliative Medicine 2012; 15(8): 902-909.

Iglesias DA, Westin SN, Rallapalli V, Huang M, Fellman B, Urbauer D, Frumovitz M, Ramirez PT, Soliman PT. The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecologic Oncology 2012; 125(2): 336-342.

Parker PA, Swartz R, Fellman B, Urbauer D, Li Y, Pisters LL, Rosser CJ, Wood CG, Matin SF. Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery. Journal of Urology 2012; 187(3): 822-826.

Updated October 1, 2015

© 2015 The University of Texas MD Anderson Cancer Center